摘要
本文研究了降低颅内压的新制剂二甲亚砜注射液的生产工艺和药品质量标准。临床应用,20%二甲亚砜注射液对12例脑外伤伴有颅内高压的病人进行了23例次的降颅内压治疗,结果证实二甲亚砜注射液可作为降低颅内压的药物。
the preparation and drug standard of dimethyl Sulfoxide injection were stu-died.20%dimethyl sulfoxide injection was used for clinical application,to control theintracranial pressure 12 for 23 cases of patients with brain injury,the result showedthat dimethyl sulfoxide injection could be used for reducing intracranial pressure.
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
1990年第3期116-118,共3页
Chinese Journal of Hospital Pharmacy